Fenalti Gustavo, Abola Enrique E, Wang Chong, Wu Beili, Cherezov Vadim
Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
Methods Enzymol. 2015;557:417-37. doi: 10.1016/bs.mie.2014.12.008. Epub 2015 Mar 17.
Crystallization of integral membrane proteins (MPs) is notoriously difficult, given their poor stability outside native membrane environment and due to the interference of detergent micelles with crystallization process. MP crystallization in a membrane mimetic matrix, known as lipidic cubic phase (LCP), has recently started to gain popularity, following successes in structure determination of G protein-coupled receptors (GPCRs), transporters, and enzymes. Unlike crystallization trials in aqueous solutions where protein molecules are free to move, diffusion of MPs in LCP is restricted, and, thus, a high level of protein mobility can serve as an early indication for subsequent crystallization success. Prompted by our initial observations that precipitant conditions can dramatically affect diffusion of GPCRs in LCP, we have developed a simple precrystallization assay, based on measuring protein diffusion at a number of different conditions by fluorescence recovery after photobleaching (LCP-FRAP). Over the last few years, the LCP-FRAP assay was incorporated in our GPCR structure determination pipeline and proved as a powerful technique allowing for a faster identification of crystallization conditions for many different receptors. The assay is used to screen for the best protein constructs, ligands, LCP host lipids, precipitants, and additives, thereby focusing subsequent crystallization trials on the most promising parts of the multidimensional crystallization phase diagram, substantially increasing the likelihood of finding the right crystallization condition. Here, we describe our LCP-FRAP protocols for guiding GPCR crystallization, which can be adapted to any other MP, and discuss some of the critical considerations related to application of this assay.
整合膜蛋白(MPs)的结晶非常困难,这是因为它们在天然膜环境之外稳定性较差,且去污剂胶束会干扰结晶过程。在膜模拟基质(即脂立方相,LCP)中进行MP结晶,最近开始受到欢迎,此前在G蛋白偶联受体(GPCRs)、转运蛋白和酶的结构测定方面取得了成功。与蛋白质分子可自由移动的水溶液结晶试验不同,MPs在LCP中的扩散受到限制,因此,高水平的蛋白质流动性可作为后续结晶成功的早期指标。基于我们最初的观察结果,即沉淀剂条件可显著影响GPCRs在LCP中的扩散,我们开发了一种简单的预结晶测定方法,即通过光漂白后荧光恢复(LCP-FRAP)在多个不同条件下测量蛋白质扩散。在过去几年中,LCP-FRAP测定已纳入我们的GPCR结构测定流程,并被证明是一种强大的技术,可更快地为许多不同受体确定结晶条件。该测定用于筛选最佳的蛋白质构建体、配体、LCP主体脂质、沉淀剂和添加剂,从而将后续结晶试验集中在多维结晶相图中最有希望的部分,大大增加找到合适结晶条件的可能性。在此,我们描述了用于指导GPCR结晶的LCP-FRAP方案,该方案可适用于任何其他MP,并讨论了与该测定应用相关的一些关键注意事项。